J
Jacob Cohen
Researcher at State University of New York System
Publications - 9
Citations - 115255
Jacob Cohen is an academic researcher from State University of New York System. The author has contributed to research in topics: Prostate cancer & Competence (human resources). The author has an hindex of 5, co-authored 6 publications receiving 104080 citations. Previous affiliations of Jacob Cohen include SUNY Downstate Medical Center & University of North Carolina at Chapel Hill.
Papers
More filters
Book
Statistical Power Analysis for the Behavioral Sciences
TL;DR: The concepts of power analysis are discussed in this paper, where Chi-square Tests for Goodness of Fit and Contingency Tables, t-Test for Means, and Sign Test are used.
Journal ArticleDOI
Ureteropyeloscopic treatment of large, complex intrarenal and proximal ureteral calculi
TL;DR: In this article, the authors defined the safety and efficacy of retrograde Ureteroscopic lithotripsy in treating large, non-infectious intrarenal and proximal ureteral stone burdens.
Journal ArticleDOI
Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
Jacob Cohen,Jacob Cohen,Victor J. Schoenbach,Jay S. Kaufman,James A. Talcott,Anna P. Schenck,Sharon Peacock,Michael J. Symons,M. Ahinee Amamoo,William R. Carpenter,Paul A. Godley +10 more
TL;DR: Earlier recurrence of prostate cancer may help explain black patients’ increased risk of mortality from prostate cancer, and black race predicted shorter disease-free survival among surgery patients, but not among radiation patients.
Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer3
Jacob Cohen,Victor J. Schoenbach,Jay S. Kaufman,James A. Talcott,Anna P. Schenck,Sharon Peacock,Michael J. Symons,M. Ahinee Amamoo,William R. Carpenter,Paul A. Godley +9 more
TL;DR: Investigating differences in disease-free survival among white, black, Hispanic, and Asian patients in a large, population-based database finds that quality of life and risk of prostate-cancer specific death following definitive treatment are affected.
Journal ArticleDOI
Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer.
TL;DR: Patients with PSA recurrence and a negative post-radiation biopsy have a high chance of persistent local disease, progression, and death from prostate cancer.